Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
How Are Robotics and AI Redefining Lab Automation in the Middle East?
Infrastructure & Management How Are Robotics and AI Redefining Lab Automation in the Middle East?

The rapid evolution of robotics and artificial intelligence (AI) is transforming laboratory automation in the Middle East, driving significant advancements in efficiency, precision, and productivity. As the region prepares for Medlab Middle East 2025 – Intelligent Health.tech, the spotlight is on t

How Is Modivcare Transforming Healthcare for Vulnerable Populations?
Patient Care How Is Modivcare Transforming Healthcare for Vulnerable Populations?

Modivcare is redefining healthcare by leveraging digital and virtual care platforms to extend quality care beyond traditional clinical settings. The company's focus on improving healthcare accessibility, equity, and proactive care has made significant strides in addressing the needs of

Advancements in Remote Patient Monitoring with POC Diagnostic Tools
Digital Health Advancements in Remote Patient Monitoring with POC Diagnostic Tools

In recent years, the landscape of healthcare has been vastly transformed by advancements in remote patient monitoring (RPM) and point-of-care (POC) diagnostic tools. These innovations are not merely enhancing the convenience of telehealth services, but they are also revolutionizing how patients and

Epic Systems Faces Antitrust Lawsuit by Particle Health Over EHR Practices
Digital Health Epic Systems Faces Antitrust Lawsuit by Particle Health Over EHR Practices

The legal battle between Epic Systems and Particle Health has captured the attention of the healthcare industry. Particle Health has filed an antitrust lawsuit against Epic Systems, accusing the electronic health record (EHR) giant of engaging in monopolistic and anticompetitive practices. This

What's Next for AI in Medtech: Key Trends to Watch in 2025?
Imaging & Diagnostics What's Next for AI in Medtech: Key Trends to Watch in 2025?

As 2024 recedes into the annals of history, the spotlight on artificial intelligence (AI) in the medtech industry has only grown brighter. Major players like GE Healthcare, Medtronic, and Dexcom have introduced new AI features, while companies such as Stryker and Quest Diagnostics have expanded

Will Centralus Health Merger Improve Care and Cut Costs for Patients?
Digital Health Will Centralus Health Merger Improve Care and Cut Costs for Patients?

On January 7, Cayuga Health and Arnot Health announced their intention to merge and form a new healthcare system named Centralus Health. This merger, which has been in the works since April 2023, is still awaiting regulatory approval from the New York State Department of Health (DOH). Despite the

Gadoquatrane: New MRI Agent Cuts Gadolinium Dose While Keeping Quality
Imaging & Diagnostics Gadoquatrane: New MRI Agent Cuts Gadolinium Dose While Keeping Quality

In a groundbreaking development in medical imaging, Bayer has introduced a new gadolinium-based contrast agent (GBCA) known as gadoquatrane, which has demonstrated the capability to use 60% less gadolinium compared to traditional agents while maintaining high imaging quality. This innovation is

How Will DEA's New Rules Impact Telemedicine Controlled Prescriptions?
Digital Health How Will DEA's New Rules Impact Telemedicine Controlled Prescriptions?

The Drug Enforcement Administration (DEA) has unveiled a series of proposed updates aimed at reshaping the landscape of controlled substance prescriptions via telemedicine. Issued as a notice of proposed rulemaking (NPRM) on January 15, 2025, these regulations seek to introduce a more stringent

EU Cyber Resilience Act: Ensuring Cybersecurity for Smart Devices
Patient Care EU Cyber Resilience Act: Ensuring Cybersecurity for Smart Devices

The European Union has introduced the Cyber Resilience Act (CRA), a comprehensive regulation that mandates the cybersecurity responsibilities of manufacturers, distributors, and retailers of smart connected devices. As the world becomes increasingly dependent on connected technology, it is crucial

DEA Proposes Telehealth Rules for Prescribing Controlled Substances
Digital Health DEA Proposes Telehealth Rules for Prescribing Controlled Substances

The U.S. Drug Enforcement Agency (DEA) has recently unveiled a regulatory framework aimed at governing the telehealth prescribing of controlled substances. This initiative seeks to maintain the accessibility of telehealth services that became prevalent during the COVID-19 pandemic while ensuring

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later